cerevasc, Author at CereVasc | Neurological Disease Device Company

About cerevasc

This author has not yet filled in any details.
So far cerevasc has created 21 blog entries.

02 Oct, 2024

A minimally invasive endovascular approach to the cerebellopontine angle cistern enables broad CNS biodistribution of scAAV9-CB-GFP

cerevasc2024-10-15T17:40:15+00:00October 2nd, 2024|Tags: Molecular Therapy|

25 Sep, 2024

CereVasc Announces Journal of Molecular Therapy Publication Highlighting the eShunt® Platform as a CNS Gene Therapy Delivery Method

cerevasc2024-10-14T16:23:47+00:00September 25th, 2024|

17 Sep, 2024

CereVasc Announces Enrollment of the 50th Patient in Pilot Studies of the eShunt® System for Normal Pressure Hydrocephalus

cerevasc2024-10-14T16:19:05+00:00September 17th, 2024|

28 Aug, 2024

eShunt® System Receives FDA Breakthrough Device Designation

cerevasc2024-10-14T16:15:33+00:00August 28th, 2024|

07 May, 2024

CereVasc Receives FDA IDE Approval for the STRIDE Pivotal Study of the eShunt System for Treatment of Normal Pressure Hydrocephalus

cerevasc2024-05-28T21:43:24+00:00May 7th, 2024|

07 Feb, 2024

CereVasc’s eShunt® System to be Presented at the International Stroke Conference by Dr. Pedro Lylyk

cerevasc2024-05-10T14:17:27+00:00February 7th, 2024|

23 Jan, 2024

Prevalence of Possible Idiopathic Normal Pressure Hydrocephalus in Sweden

cerevasc2024-02-16T22:39:04+00:00January 23rd, 2024|

23 Jan, 2024

CereVasc’s eShunt® System Study Data Presented at the ABC WIN Seminar

cerevasc2024-10-14T16:28:16+00:00January 23rd, 2024|

27 Oct, 2023

Cerebral venous disorders: Diagnosis and endovascular management

cerevasc2024-10-15T17:43:05+00:00October 27th, 2023|Tags: Journal of Neuroradiology|

10 Feb, 2021

First patient treated in CereVasc clinical trial of eShunt™ System for communicating hydrocephalus

cerevasc2023-02-14T15:48:38+00:00February 10th, 2021|